The present invention discloses oral isotonic compositions to provide hydration to mammals in need, comprising a prebiotic oligosaccharide or fructo-oligosaccharide and at least three members of the group consisting of steviol glycoside, citric acid monohydrate, glutamic acid, monosodium glutamate and glycine.

Protein-rich nutrient supplements and animal feed supplements derived from an anaerobic bacterial process are generated through a myriad of cell rupturing and protein fractionation/purification processes. Bacterial fermentation systems and methods of obtaining one or more protein-containing portions from a fermentation process using carbon monoxide-containing gaseous substrates are provided. The invention further provides compositions of protein-rich nutrient supplements with useful applications for intake by a variety of different animals and humans.

The present invention discloses a native rapeseed protein isolate comprising 40 to 65% cruciferins and 35 to 60% napins and having a solubility of at least 88% when measured over a pH range from 3 to 10 at a temperature of 23±2° C.; wherein the native rapeseed protein isolate comprises from 5% to 65% on dry matter of 12S rapeseed protein where the presence of 12S is verified by Blue Native PAGE.

The present invention discloses a native rapeseed protein isolate comprising 40 to 65% cruciferins and 35 to 60% napins and having a solubility of at least 88% when measured over a pH range from 3 to 10 at a temperature of 23±2° C.; wherein the native rapeseed protein isolate comprises from 5% to 65% on dry matter of 12S rapeseed protein where the presence of 12S is verified by Blue Native PAGE.

Described herein are controlled release pet food compositions comprising: a matrix comprising: a fiber component comprising a high solubility fiber source and low solubility fiber source, and a polyphenol source; wherein the matrix is adapted to deliver the polyphenol source to the lower gastrointestinal (GI) tract of a mammal after ingestion by the mammal. Methods of making and using these compositions are also described.

Described herein are controlled release pet food compositions comprising: a matrix comprising: a fiber component comprising a high solubility fiber source and low solubility fiber source, and a polyphenol source; wherein the matrix is adapted to deliver the polyphenol source to the lower gastrointestinal (GI) tract of a mammal after ingestion by the mammal. Methods of making and using these compositions are also described.

A composition contains quercetagetin and 6-hydroxykaempferol, and, optionally further includes patuletin. The composition has an excellent antioxidant effect, and can be used as an active additive in food, drugs, health care products, cosmetics, and feed. In addition, the composition can prompt animal growth, reduce ratio of feed to gain, and improve meat quality in the feed.

The present disclosure relates to a composition for prevention or treatment of cancer, the composition containing, as an active ingredient, a strain belonging to the genus Leuconostoc, isolated from kimchi, or a culture thereof. The genus Leuconostoc strain or the culture thereof according to the present disclosure exhibits excellent anticancer activity, and thus can be advantageously used as a composition for use in treatment, prevention, alleviation, or the like, of human or animal cancer.

The present invention is intended to provide a lactic acid bacterium-containing composition that is effective for suppression of the onset of allergies. More specifically, the present invention relates to a composition comprising lactic acid bacteria belonging to Lactobacillus animalis, wherein the composition is provided in the form of, for example, a food or beverage composition, a pharmaceutical composition, a feed composition, a sanitary composition or the like. Furthermore, the present invention provides a method for preventing the onset of allergies.

Use of a seaweed blend to modify gastrointestinal (GI) microbiota of an animal host. Modifying the GI microbiota may comprise modifying a community of bacteria, wherein the community of bacteria comprises Firmicutes and Bacteriodetes and the seaweed blend modifies the ratio of Firmicutes to Bacteriodetes, such as increasing the ratio of Firmicutes to Bacteriodetes. Further, the seaweed blend modifies specific families of commensal bacteria families including Ruminococceae and Lachnospiraceae within the Phyla Firmicutes. The seaweed blend may comprise (i) 65-80 wt % Ulva; (ii) 3-8 wt % Gracilaria; and (iii) 15-25 wt % Sargassum and/or Ascophyllum.